Form 4 for NVAX NOVAVAX INC
Accepted 2025-02-05 00:00:00 ET · period of report 2024-03-31 · accession 0001104659-25-009786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-05 | 2024-03-31+ | NVAX | Alton Gregg H | Dir | A - Grant | $8.50 | +7,915 | 15.1K | +110% | +$67.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-31 | A | A | 3,420 | $4.90 | 7,220 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-31 | A | A | 1,982 | $8.61 | 18,385 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-30 | A | A | 1,311 | $12.77 | 16,403 | D | — | — | |
| 4 | Common | Common Stock | 2024-06-30 | A | A | 1,202 | $13.93 | 15,092 | D | — | — |